Applied Therapeutics
APLT
APLT was delisted on the 2nd of February, 2026.
36 hedge funds and large institutions have $15.6M invested in Applied Therapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 11 increasing their positions, 9 reducing their positions, and 9 closing their positions.
22% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 9
4% more capital invested
Capital invested by funds: $15.1M → $15.6M (+$570K)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.88% less ownership
Funds ownership: 40.95% → 40.07% (-0.88%)
5% less funds holding
Funds holding: 38 → 36 (-2)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SAM
Simplify Asset Management
Las Vegas,
Nevada
|
+$2.35M |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$985K |
| 3 |
Citigroup
New York
|
+$348K |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$181K |
| 5 |
Millennium Management
New York
|
+$118K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$2.32M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$462K |
| 3 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$355K |
| 4 |
AG
Artal Group
Luxembourg
|
-$304K |
| 5 |
Two Sigma Advisers
New York
|
-$98.6K |
APLT Hedge Fund Activity: Q1 2023 in Review
36 of the 6,284 institutional investors tracked by Wall St. Rank reported a position in Applied Therapeutics (APLT) for Q1 2023, worth a combined $15.6M — up 3.8% from $15.1M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of APLT and 7 opened new positions — a net loss of 2 holders — while 9 trimmed existing stakes and 11 added.
The largest buyer was Simplify Asset Management, opening a new position worth an estimated $2.35M. The largest seller was OrbiMed, exiting entirely with an estimated $2.32M sold.
- 36 institutional investors held Applied Therapeutics (APLT) as of Q1 2023, down from 38 in Q4 2022.
- Funds reported $15.6M of Applied Therapeutics stock for Q1 2023, up 3.8% quarter-over-quarter.
- 7 funds opened new Applied Therapeutics positions in Q1 2023 and 9 closed out, a net change of -2 holders.
- The largest Applied Therapeutics buyer in Q1 2023 was Simplify Asset Management, an estimated $2.35M added.
- The largest Applied Therapeutics seller in Q1 2023 was OrbiMed, an estimated $2.32M sold.
Based on aggregated 13F filings for Q1 2023.